Loading, Please Wait...

CST: 26/05/2019 04:14:21   

Assure Holdings Appoints Kelsie Jas as Director of Revenue Cycle Management

57 Days ago

DENVER, March 29, 2019 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (TSXV: IOM; OTCQB: ARHH), a provider of intraoperative neuromonitoring services, has appointed Kelsie Jas as director of revenue cycle management.

Jas brings over 13 years of hands-on revenue cycle management experience from large hospital settings to smaller healthcare clinics. Most recently, she served as revenue cycle manager for Arapahoe House in Thornton, Colorado, and physician billing supervisor & IT system analyst for the Denver Health & Hospital Authority in Denver, Colorado.

“Kelsie brings to Assure great depth of knowledge and experience in revenue cycle management and related IT systems that will be instrumental for our growth,” said Paul Webster, Assure’s vice president of strategy. “Kelsie has already brought meaningful improvements to our revenue cycle operations and continues to add great value to our ongoing focus on bolstering the billing and collections process.”

This appointment supports the Company’s strategy to further enhance revenue cycle management and reduce the business risk associated with the billing collections process.

Jas commented on her appointment: “Having led multiple billing and collection teams, I understand the revenue cycle management process from beginning to end. I look forward to applying my background and expertise to increase the efficiency and effectiveness of Assure’s revenue cycle activity.”

Jas holds a Bachelor of Science degree in business administration from the University of Denver and also has a Lean Six Sigma Black Belt Certificate. Jas is currently pursuing her Master of Business Administration degree at the University of Colorado, Denver.

About Assure Holdings

Assure Holdings Corp. is a Colorado-based company that works with neurosurgeons and orthopedic spine surgeons to provide a turnkey suite of services that support intraoperative neuromonitoring activities during invasive surgeries. Assure employs its own staff of technologists and uses its own state-of-the-art monitoring equipment, handles 100% of intraoperative neuromonitoring scheduling and setup, and bills for all technical services provided. While Assure focuses primarily on supporting spinal and vascular surgeries, plans are in place to support other classes of medicine that rely on the standard of care that intraoperative neuromonitoring provides. For more information, visit the company’s website at www.assureneuromonitoring.com.

Forward-Looking Statements

This news release contains certain statements that may constitute forward-looking information under applicable securities laws. All statements, other than those of historical fact, which address activities, events, outcomes, results, developments, performance or achievements that Assure anticipates or expects may or will occur in the future (in whole or in part) should be considered forward-looking information. Such information may involve, but is not limited to, comments with respect to strategies, expectations, planned operations and future actions of the Company. Often, but not always, forward-looking information can be identified by the use of words such as "plans", "expects", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates", or "believes" or variations (including negative variations) of such words and phrases, or statements formed in the future tense or indicating that certain actions, events or results "may", "could", "would", "might" or "will" (or other variations of the forgoing) be taken, occur, be achieved, or come to pass. Forward-looking information is based on currently available competitive, financial and economic data and operating plans, strategies or beliefs as of the date of this news release, but involve known and unknown risks, uncertainties, assumptions and other factors that may cause the actual results, performance or achievements of Assure to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information. Such factors may be based on information currently available to Assure, including information obtained from third-party industry analysts and other third-party sources, and are based on management's current expectations or beliefs regarding future growth, results of operations, future capital (including the amount, nature and sources of funding thereof) and expenditures. Any and all forward-looking information contained in this press release is expressly qualified by this cautionary statement.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

The securities of the Corporation have not been and will not be registered under the United States Securities Act of 1933, as amended and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirement. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful.

Contacts

John Farlinger, Executive Chairman
Assure Holdings Corp.
(604) 763-7565
John.Farlinger@assureiom.com

Cody Slach, Managing Director
Liolios Investor Relations
(949) 574-3860
IOM@Liolios.com

Is your business listed correctly on America’s largest city directory network of 1,000 portals?